Praxis Precision Medicines (PRAX) Tax Provisions (2020 - 2021)

Praxis Precision Medicines (PRAX) posted quarterly Tax Provisions of -$5000.0 for Q4 2021, down 200.0% quarter-over-quarter from $5000.0 in Q3 2021.

Praxis Precision Medicines (PRAX) Tax Provisions (2020 - 2021) Analysis & Trends

Praxis Precision Medicines' Tax Provisions history runs 2 years deep, the most recent figure standing at -$5000.0 for Q4 2021.

In Q4 2021, Tax Provisions changed N/A year-over-year to -$5000.0; the TTM figure through Sep 2021 stood at $5000.0 (changed N/A YoY), while the FY2020 annual figure was -$8000.0, up 90.48% from the prior year.
Tax Provisions for Q4 2021 stood at -$5000.0, down from $5000.0 in the prior quarter.
The five-year high for Tax Provisions was $5000.0 in Q3 2021, with the low at -$11000.0 in Q1 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	59.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	75.45 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	267.73
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	13.31 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	1.90 Mn
10	Praxis Precision Medicines	10.24 Bn	9.48 Bn	-	-

Download Data